Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Comparability of ABP 501-HCF and ABP 501-LCF in Healthy Adults
NCT05909852Phase 1Completed
- Sponsor
- Amgen
- Start
- Jul 2021
- Primary completion
- Nov 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of adalimumab (2 arms), sponsored by Amgen. Primary endpoints: Area Under the Serum Concentration-Time Curve from Time 0 Extrapolated to Infinity and Maximum Observed Serum Concentration. Started Jul 2021; status: completed.
02
Drugs
Beyond the preview
Go deeper on NCT05909852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05909852.